Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucose monohydrate 20g/Sod chlor 3.5g/Sod bicarb 2.5g pdr
0902012H0AAAKAK
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 86 |
|
Generic Dioralyte oral powder sachets
0902012H0AAAEAE
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 29 |
|
Generic O.R.S Oral Rehydration Salts ORS soluble tablets
0902012H0AAANAN
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 8 |
|
Generic Dioralyte Relief oral powder sachets sugar free
0902012H0AAAJAJ
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 3 |
|
Generic Dioralyte effervescent tablets sugar free
0902012H0AAAAAA
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | No data available |
|
Generic Electrolade oral powder sachets
0902012H0AAADAD
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | No data available |
|
Generic Electrorush ORS oral powder sachets
0902012H0AAAQAQ
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | No data available |
|
Generic Electrorush ORS oral rehydration salts drink SF
0902012H0AAAPAP
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | No data available |
|
Generic O.R.S Kids Oral Rehydration Salts ORS soluble tab
0902012H0AAARAR
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | No data available |
|
Generic Rehidrat oral powder 14g sachets
0902012H0AAAFAF
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.